FDA Offers Hearing on Agri-Tech's Proposal to Withdraw Approval of New Animal Drug Application

Summary

The FDA is allowing a public hearing on Agri-Tech, Inc.'s request to withdraw approval of its new animal drug application, Protamone-D, due to the company's failure to submit required reports, as mandated by the FDA.